You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for naphazoline hydrochloride; pheniramine maleate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01533220 ↗ Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal Completed EMS Phase 3 2013-01-01 The common cold is a major cause of nasal obstruction and reaches children and adults two or more times a year. At the moment, there is no cure for the common cold, and therefore the reduction of symptoms is the focus of the treatment. The study has parallel distribution design, with two equal groups, in which one group will be treated by a combination of naphazoline hydrocloride + pheniramine maleate + panthenol and the other will receive treatment with naphazoline hydrocloride.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for naphazoline hydrochloride; pheniramine maleate

Condition Name

Condition Name for naphazoline hydrochloride; pheniramine maleate
Intervention Trials
Allergic Disorder of Respiratory System 1
Cold 1
Flu 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for naphazoline hydrochloride; pheniramine maleate
Intervention Trials
Hypersensitivity 1
Respiration Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for naphazoline hydrochloride; pheniramine maleate

Trials by Country

Trials by Country for naphazoline hydrochloride; pheniramine maleate
Location Trials
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for naphazoline hydrochloride; pheniramine maleate

Clinical Trial Phase

Clinical Trial Phase for naphazoline hydrochloride; pheniramine maleate
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for naphazoline hydrochloride; pheniramine maleate
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for naphazoline hydrochloride; pheniramine maleate

Sponsor Name

Sponsor Name for naphazoline hydrochloride; pheniramine maleate
Sponsor Trials
EMS 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for naphazoline hydrochloride; pheniramine maleate
Sponsor Trials
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.